MeCP2 inhibits ischemic neuronal injury by enhancing methylation of the FOXO3a promoter to repress the SPRY2-ZEB1 axis
Lei Meng(Shandong Provincial Hospital), Guangyu Zhao(Changchun University of Science and Technology), Zhihao Fang(Xi'an University of Architecture and Technology), Bin Feng(Dalian Medical University), Liming Luan(Golden Concord Group (China))
Cited by 23
Related Papers
Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery
|Bioconjugate Chemistry|2011|424
Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications
|European Polymer Journal|2016|175
Towards the Automatic Anime Characters Creation with Generative Adversarial Networks
|arXiv (Cornell University)|2017|136
Cascaded filter deterministic lateral displacement microchips for isolation and molecular analysis of circulating tumor cells and fusion cells
|Lab on a Chip|2021|84
Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor
|Journal of Controlled Release|2012|80